Molecular basis of cerebral neurodegeneration in prion diseases.
about
The novel sorting nexin SNX33 interferes with cellular PrP formation by modulation of PrP sheddingThe ubiquitin-proteasome system in spongiform degenerative disordersIntroducing a rigid loop structure from deer into mouse prion protein increases its propensity for misfolding in vitroPathologic prion protein infects cells by lipid-raft dependent macropinocytosisInteraction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues.Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entryProteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion proteinInfectious prion protein alters manganese transport and neurotoxicity in a cell culture model of prion disease.The variant Creutzfeldt-Jakob Disease: Risk, uncertainty or safety in the use of blood and blood derivatives?Therapeutic approaches for prion and Alzheimer's diseases.Prion diseases: from protein to cell pathology.Prion protein modulates cellular iron uptake: a novel function with implications for prion disease pathogenesisMolecular pathology of human prion diseases.Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration.CpG and LPS can interfere negatively with prion clearance in macrophage and microglial cells.Effect of PrP105-132 on the secretion of interleukin-6 and interleukin-8 from microglial cells in vitro.
P2860
Q24322760-4943F468-E82C-43E4-AACF-E2ACE157B4B1Q28386906-1C1AB958-4990-4D3B-A876-4633751E08F9Q28534310-2FFC4406-F51C-48C7-9E71-4D2F244CC395Q33434501-DD718F7A-E4C9-432F-A778-2A4C87DBE1CBQ34074414-77285871-87DB-4349-81BC-A4C3B04E2B7BQ35177001-148DC5B4-5421-445E-8589-ABA7AF602CECQ35311053-E8FE95DD-E4C9-4EB6-ACEC-18DFEA425FD2Q35499246-410019FD-246A-4A77-80FE-5A91B108CDEEQ36743340-9FB2B95A-2463-4D48-B5AC-6F654CEC89B1Q36872884-380A9A18-6114-4BEB-8B5B-B6C0102F7C15Q37075786-07EDF7EF-D7CB-47EF-9C43-7703CB92B4EDQ37087487-5B197D8E-76F6-452C-B3CD-54FC43D1BCEDQ37462236-D421192C-9962-4829-A1BE-7E194E8B39BEQ38081918-142D440A-5D93-4004-A0A7-9ACC567D52A2Q38085466-2EE82ACF-DBA7-4204-8332-A4AC033F95B4Q40066013-61EF6B17-4CED-47AC-91E7-94E6E9510639Q49335486-1626630D-4FA1-4A64-91DF-922272C3C032
P2860
Molecular basis of cerebral neurodegeneration in prion diseases.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Molecular basis of cerebral neurodegeneration in prion diseases.
@ast
Molecular basis of cerebral neurodegeneration in prion diseases.
@en
type
label
Molecular basis of cerebral neurodegeneration in prion diseases.
@ast
Molecular basis of cerebral neurodegeneration in prion diseases.
@en
prefLabel
Molecular basis of cerebral neurodegeneration in prion diseases.
@ast
Molecular basis of cerebral neurodegeneration in prion diseases.
@en
P2860
P1433
P1476
Molecular basis of cerebral neurodegeneration in prion diseases
@en
P2093
Hermann M Schätzl
P2860
P304
P356
10.1111/J.1742-4658.2007.05633.X
P407
P577
2007-02-01T00:00:00Z